Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:52:47.646Z.
Calculation as of: 2026-10-06T18:52:47.646Z.
Quote observation: 2026-10-06T18:50:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 64600f38e310d2eb3cd81a0b95bf77f6abd31b9de5548b9cdd3f3c9d46967593
EARNINGS YIELD
N/A
PROCEPT BioRobotics Corporation
Market Cap
$985.00M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$988.52M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$988.20M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$990.27M
Earnings Yield
6.64%
TTM Avg
5.51%
3Y Avg
5.51%
5Y Avg
5.51%
Market Cap
$979.09M
Earnings Yield
1.41%
TTM Avg
1.18%
3Y Avg
2.75%
5Y Avg
2.30%
Market Cap
$1.01B
Earnings Yield
N/A
TTM Avg
17.88%
3Y Avg
17.88%
5Y Avg
17.88%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PROCEPT BioRobotics Corporation (PRCT) | $985.00M | N/A | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $988.52M | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $988.20M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $990.27M | 6.64% | 5.51% | 5.51% | 5.51% |
| Pacira BioSciences, Inc. (PCRX)vs › | $979.09M | 1.41% | 1.18% | 2.75% | 2.30% |
| Vor Biopharma Inc. (VOR)vs › | $996.36M | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $965.04M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.01B | N/A | 17.88% | 17.88% | 17.88% |
| Immatics N.V. (IMTX)vs › | $1.01B | N/A | 3.22% | 5.54% | 5.54% |
| Savara Inc. (SVRA)vs › | $953.94M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
